-
Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template
PharmaSources
May 10, 2024
Nucleic Acid Medicines Manufacture, Round 2 call.
-
First Study Using Biomimetic AI Digital Twins And Multiomics in Genetics Research
PharmaSources
April 07, 2024
The Application of Knowledge Engineering via the use of a Biomimetic Digital Twin Ecosystem, Phenotype DrivenVariant Analysis, and Exome Sequencing to Understand the Molecular Mechanisms of Disease.
-
SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
B3C newswire
November 06, 2023
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK).
-
Adhering to Life's Simple 7 May Cut CHD Risk Despite Genetics
drugs.com
February 08, 2022
Ideal adherence to the American Heart Association (AHA) Life's Simple 7 (LS7) guidelines is associated with a lower lifetime risk for coronary heart disease (CHD)...
-
Decode Genetics Publishes the Largest Ever Study of the Plasma Proteome
prnasia
December 03, 2021
In a study published today in Nature genetics, scientists at deCODE genetics , a subsidiary of the pharmaceutical company Amgen, demonstrate how measuring the levels of a large number of proteins...
-
The Journal of Medicinal Chemistry Publishes Study Showing Potential of the Potent EED Inhibitor EEDi-5273 (APG-5918) to Achieve Complete Tumor Regression by Modulating the Epigenetics
prnasia
October 19, 2021
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a research team...
-
deCODE genetics - New study on inheritance and fetal growth
prnasia
July 20, 2021
In a paper published in Nature genetics, Scientists from deCODE genetics, a fully owned subsidiary of Amgen, report sequence variants that associate with birth weight and demonstrate how these variants affect birth weight through both the maternal and ...
-
deCODE genetics: Predicting the probability of death
prnasia
June 18, 2021
Scientists from deCODE genetics have developed a predictor based on protein measurements in blood samples that predicts the time to all-cause death better than traditional risk factors.
-
deCODE genetics - Rounding off the human genome
prnasia
May 11, 2021
In a study published , scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits.
-
Catalent Acquires Delphi Genetics
contractpharma
February 24, 2021
Launches US plasmid manufacturing site to establish global pDNA development and manufacturing capabilities.